Alopex Pharmaceuticals Inc., Sequana deal

The privately held companies will collaborate to identify, map and clone genes associated with androgenetic alopecia (common baldness) as well as genes associated with excessively long hair growth. Androgenetic alopecia affects about 40 percent of men (pattern baldness) and 20 to 25 percent of women (diffuse hair loss) by age 40. ...